| Bioactivity | TREX1-IN-2 (Compound 15B) is an inhibitor of TREX1 with an IC50 vaule of in vivo[1]. |
| Target | IC50: < 1.00 μM (Human TREX1). |
| CAS | 2580192-18-1 |
| Formula | C28H34Cl2N4O4 |
| Molar Mass | 561.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jeffrey J. Letourneau, et al. Substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines as TREX1 inhibitors. Patent, US11583538B2, 2023-02-21. |
TREX1-IN-2
CAS: 2580192-18-1 F: C28H34Cl2N4O4 W: 561.50
TREX1-IN-2 (Compound 15B) is an inhibitor of TREX1 with an IC50 vaule of < 1.00 μM against Human TREX1. TREX1-IN-2 exhi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.